At peak tracer uptake (2 h post-injection of 125I) the FRTL-Tc-NIS tumors exhibited a mean of 19.3-times the serum 125I concentration and a remarkable 48.3-times the control FRTL tumor concentration. Here, SLC5A5 is linked to neoplasm.